All Stories

  1. Yersiniabactin contributes to overcoming zinc restriction during Yersinia pestis infection of mammalian and insect hosts

    Article • Proceedings of the National Academy of Sciences, October 2021, Proceedings of the National Academy of Sciences

    Matthew B Lawrenz

  2. Lemon Exosome-like Nanoparticles-Manipulated Probiotics Protect Mice from C. diff Infection

    Article • iScience, October 2020, Elsevier

    Matthew B Lawrenz

  3. Recombinant Human Plasma Gelsolin Improves Survival and Attenuates Lung Injury in a Murine Model of Multidrug-Resistant Pseudomonas aeruginosa Pneumonia

    Article • Open Forum Infectious Diseases, June 2020, Oxford University Press (OUP)

    Matthew B Lawrenz

  4. Redundant and Cooperative Roles for Yersinia pestis Yop Effectors in the Inhibition of Human Neutrophil Exocytic Responses Revealed by Gain-of-Function Approach

    Article • Infection and Immunity, February 2020, ASM Journals

    Matthew B Lawrenz

  5. Robust Th1 cellular and humoral responses generated by the Yersinia pestis rF1-V subunit vaccine formulated to contain an agonist of the CD137 pathway do not translate into increased protection against pneumonic plague

    Article • Vaccine, September 2019, Elsevier

    Matthew B Lawrenz

  6. The Evolution of SlyA/RovA Transcription Factors from Repressors to Countersilencers inEnterobacteriaceae

    Article • mBio, April 2019, ASM Journals

    Matthew B Lawrenz

  7. Intracellular Assays to Monitor Survival and Growth of Yersinia pestis Within Macrophages

    Article • January 2019, Springer Science + Business Media

    Matthew B Lawrenz

  8. Inflammasome-Independent Leukotriene B4Production Drives Crystalline Silica–Induced Sterile Inflammation

    Article • The Journal of Immunology, April 2018, The American Association of Immunologists

    Matthew B Lawrenz

  9. Yersinia pestis Targets the Host Endosome Recycling Pathway during the Biogenesis of the Yersinia-Containing Vacuole To Avoid Killing by Macrophages

    Article • mBio, February 2018, ASM Journals

    Matthew B Lawrenz

  10. Impact of Gentamicin Concentration and Exposure Time on Intracellular Yersinia pestis

    Article • Frontiers in Cellular and Infection Microbiology, December 2017, Frontiers

    Matthew B Lawrenz

  11. Crystal structure ofYersinia pestisvirulence factor YfeA reveals two polyspecific metal-binding sites

    Article • Acta Crystallographica Section D Structural Biology, June 2017, International Union of Crystallography

    Matthew B Lawrenz

  12. Host FIH-Mediated Asparaginyl Hydroxylation of Translocated Legionella pneumophila Effectors

    Article • Frontiers in Cellular and Infection Microbiology, March 2017, Frontiers

    Matthew B Lawrenz

  13. ZTI-01 Treatment Improves Survival of Animals Infected with Multidrug Resistant Pseudomonas aeruginosa

    Article • Open Forum Infectious Diseases, January 2017, Oxford University Press (OUP)

    Matthew B Lawrenz

  14. Zinc transporters YbtX and ZnuABC are required for the virulence of Yersinia pestis in bubonic and pneumonic plague in mice

    Article • Metallomics, January 2017, Oxford University Press (OUP)

    Matthew B Lawrenz

  15. Novel Synthesis of Kanamycin Conjugated Gold Nanoparticles with Potent Antibacterial Activity

    Article • Frontiers in Microbiology, May 2016, Frontiers

    Matthew B Lawrenz

  16. Yersinia pestis Requires Host Rab1b for Survival in Macrophages

    Article • PLoS Pathogens, October 2015, PLOS

    Matthew B Lawrenz

  17. Nanotechnology’s Impact on Medicinal Chemistry

    Article • Mini-Reviews in Medicinal Chemistry, May 2015, Bentham Science Publishers

    Matthew B Lawrenz

  18. Development and evaluation of murine lung-specific disease models for Pseudomonas aeruginosa applicable to therapeutic testing

    Article • Pathogens and Disease, April 2015, Oxford University Press (OUP)

    Matthew B Lawrenz

  19. Heterogeneous Immunological Landscapes and Medieval Plague: An Invitation to a New Dialogue between Historians and Immunologists

    Article • The Medieval Globe, January 2015, Arc Medieval Press, Medieval Institute Publications (Western Michigan University)

    Matthew B Lawrenz

  20. Intubation-mediated Intratracheal (IMIT) Instillation: A Noninvasive, Lung-specific Delivery System

    Article • Journal of Visualized Experiments, November 2014, MyJove Corporation

    Matthew B Lawrenz

  21. Improving the Th1 cellular efficacy of the lead Yersinia pestis rF1-V subunit vaccine using SA-4-1BBL as a novel adjuvant

    Article • Vaccine, September 2014, Elsevier

    Professor Haval Shirwan, Matthew B Lawrenz

  22. Bioluminescent Imaging of Bacteria During Mouse Infection

    Article • October 2013, Springer Science + Business Media

    Matthew B Lawrenz

  23. Acquisition of omptin reveals cryptic virulence function of autotransporter YapE in Yersinia pestis

    Article • Molecular Microbiology, June 2013, Wiley

    Professor Virginia L Miller, Matthew B Lawrenz

  24. Development of Bioluminescent Bioreporters for In Vitro and In Vivo Tracking of Yersinia pestis

    Article • PLOS One, October 2012, PLOS

    Matthew B Lawrenz

  25. Expression during Host Infection and Localization of Yersinia pestis Autotransporter Proteins

    Article • Journal of Bacteriology, August 2011, ASM Journals

    Professor Virginia L Miller, Matthew B Lawrenz

  26. The Dependence of theYersiniapestisCapsule on Pathogenesis Is Influenced by the Mouse Background

    Article • Infection and Immunity, November 2010, ASM Journals

    Professor Virginia L Miller, Matthew B Lawrenz

  27. Model Systems to Study Plague Pathogenesis and Develop New Therapeutics

    Article • Frontiers in Microbiology, January 2010, Frontiers

    Matthew B Lawrenz

  28. A Novel Autotransporter Adhesin Is Required for Efficient Colonization during Bubonic Plague

    Article • Infection and Immunity, October 2008, ASM Journals

    Matthew B Lawrenz

  29. The Yersinia pestis autotransporter YapC mediates host cell binding, autoaggregation and biofilm formation

    Article • Microbiology, June 2008, Society for General Microbiology

    Matthew B Lawrenz

  30. Comparative Analysis of the Regulation of rovA from the Pathogenic Yersiniae

    Article • Journal of Bacteriology, June 2007, ASM Journals

    Professor Virginia L Miller, Matthew B Lawrenz

  31. Effects of vlsE Complementation on the Infectivity of Borrelia burgdorferi Lacking the Linear Plasmid lp28-1

    Article • Infection and Immunity, November 2004, ASM Journals

    Matthew B Lawrenz

  32. Invasin and beyond: regulation of Yersinia virulence by RovA

    Article • Trends in Microbiology, June 2004, Elsevier

    Professor Virginia L Miller, Matthew B Lawrenz

  33. Effect of Complement Component C3 Deficiency on Experimental Lyme Borreliosis in Mice

    Article • Infection and Immunity, August 2003, ASM Journals

    Matthew B Lawrenz

  34. A plasmid-encoded nicotinamidase (PncA) is essential for infectivity of Borrelia burgdorferi in a mammalian host

    Article • Molecular Microbiology, April 2003, Wiley

    Matthew B Lawrenz

  35. Decreased Electroporation Efficiency in Borrelia burgdorferi Containing Linear Plasmids lp25 and lp56: Impact on Transformation of Infectious B. burgdorferi

    Article • Infection and Immunity, September 2002, ASM Journals

    Matthew B Lawrenz

  36. Comparative reactivity of human sera to recombinant VlsE and other Borrelia burgdorferi antigens in class-specific enzyme-linked immunosorbent assays for Lyme borreliosis

    Article • Journal of Medical Microbiology, August 2002, Society for General Microbiology

    Matthew B Lawrenz

  37. Crystal Structure of Lyme Disease Variable Surface Antigen VlsE ofBorrelia burgdorferi

    Article • Journal of Biological Chemistry, March 2002, American Society for Biochemistry & Molecular Biology (ASBMB)

    Matthew B Lawrenz